We are live on ! Find out more
CRIG

Charter Research & Investment Group Portfolio holdings

AUM $150M
1-Year Est. Return 28.05%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+28.05%
3 Year Est. Return
+71.14%
5 Year Est. Return
+100.32%
10 Year Est. Return
AUM
$98.4M
AUM Growth
+$6.04M
Cap. Flow
-$783K
Cap. Flow %
-0.8%
Top 10 Hldgs %
40.03%
Holding
80
New
5
Increased
28
Reduced
20
Closed
2

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$715K
2
HON icon
Honeywell
HON
+$241K
3
DUK icon
Duke Energy
DUK
+$213K
4
CSX icon
CSX Corp
CSX
+$204K
5
BDX icon
Becton Dickinson
BDX
+$194K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.27M
2
GE icon
GE Aerospace
GE
+$431K
3
NEU icon
NewMarket
NEU
+$363K
4
KHC icon
Kraft Heinz
KHC
+$310K
5
JNJ icon
Johnson & Johnson
JNJ
+$300K

Sector Composition

Rank Sector Weight
1 Communication Services 18.84%
2 Healthcare 15.16%
3 Consumer Staples 14.39%
4 Technology 14.17%
5 Financials 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
26
Salesforce
CRM
$158B
$1.3M 1.32%
7,978
AGR
27
DELISTED
Avangrid, Inc.
AGR
$1.26M 1.28%
24,580
+1,160
+5% +$57.7K
EXPE icon
28
Expedia Group
EXPE
$37.3B
$1.25M 1.27%
11,600
-400
-3% -$46.9K
PM icon
29
Philip Morris
PM
$295B
$1.2M 1.22%
14,103
-937
-6% -$77.2K
MO icon
30
Altria Group
MO
$114B
$1.17M 1.19%
23,367
-3,118
-12% -$147K
AMZN icon
31
Amazon
AMZN
$2.96T
$1.1M 1.12%
11,940
+460
+4% +$40.7K
ALB icon
32
Albemarle
ALB
$15.5B
$1.07M 1.09%
14,653
-1,892
-11% -$126K
BRK.B icon
33
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.03M 1.05%
4,538
+275
+6% +$59.7K
F icon
34
Ford
F
$55.7B
$1M 1.02%
107,825
+2,750
+3% +$24.7K
AMAT icon
35
Applied Materials
AMAT
$428B
$934K 0.95%
15,300
WES icon
36
Western Midstream Partners
WES
$19.3B
$865K 0.88%
43,955
-1,450
-3% -$30.1K
CVX icon
37
Chevron
CVX
$366B
$855K 0.87%
7,095
+107
+2% +$12.6K
PAYX icon
38
Paychex
PAYX
$42.7B
$744K 0.76%
8,750
KHC icon
39
Kraft Heinz
KHC
$30B
$718K 0.73%
22,351
-10,220
-31% -$310K
PFE icon
40
Pfizer
PFE
$153B
$717K 0.73%
19,287
+332
+2% +$11.8K
KMI icon
41
Kinder Morgan
KMI
$68.7B
$713K 0.72%
33,690
+274
+0.8% +$5.55K
KO icon
42
Coca-Cola
KO
$375B
$654K 0.66%
11,809
-183
-2% -$9.84K
EPD icon
43
Enterprise Products Partners
EPD
$81.7B
$644K 0.65%
22,865
-1,800
-7% -$48.8K
PG icon
44
Procter & Gamble
PG
$339B
$635K 0.65%
5,088
JPM icon
45
JPMorgan Chase
JPM
$950B
$604K 0.61%
4,331
+600
+16% +$77K
ABBV icon
46
AbbVie
ABBV
$435B
$534K 0.54%
6,034
ABT icon
47
Abbott
ABT
$187B
$528K 0.54%
6,077
ED icon
48
Consolidated Edison
ED
$39.9B
$511K 0.52%
5,645
MCK icon
49
McKesson
MCK
$101B
$505K 0.51%
3,650
PPG icon
50
PPG Industries
PPG
$26.6B
$501K 0.51%
3,750

Similar funds

Charter Research & Investment Group's Q4 2019 Portfolio in Review

As of Q4 2019, Charter Research & Investment Group held 80 positions worth $98.4M, up 6.5% from $92.3M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Charter Research & Investment Group's Q4 2019 filing shows 5 new, 28 increased, 20 reduced and 2 closed positions. Its largest new stake was Honeywell: 1,473 shares worth $246K. The largest sale was Celgene Corp, an estimated $1.27M.

By sector, the portfolio is most concentrated in Communication Services at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Charter Research & Investment Group's largest Q4 2019 buy was Honeywell: 1,473 shares worth $246K.
  • Charter Research & Investment Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $715K increase.
  • Charter Research & Investment Group's biggest Q4 2019 reduction was GE Aerospace, cutting an estimated $431K.
  • Charter Research & Investment Group fully exited Celgene Corp in Q4 2019, selling an estimated $1.27M.
  • Charter Research & Investment Group's ten largest holdings make up 40% of its $98.4M portfolio in Q4 2019.
  • Charter Research & Investment Group opened 5 new positions and closed 2 in Q4 2019.
  • Charter Research & Investment Group's portfolio value rose 6.5% quarter-over-quarter to $98.4M.

Based on Charter Research & Investment Group's 13F filing for Q4 2019, filed 30 Jan 2020.